
HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancer: Updates and Insights
29.10.2025
0:00
30:00
Are you ready for the evolving treatment paradigm in HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancer (BTC)?
Credit available for this activity expires: 10/24/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-positive-gastroesophageal-adenocarcinoma-and-biliary-2025a1000sr3?&ecd=bdc_podcast_libsyn_mscpedu
Więcej odcinków z kanału "Keeping Current CME"



Nie przegap odcinka z kanału “Keeping Current CME”! Subskrybuj bezpłatnie w aplikacji GetPodcast.







